{
    "clinical_study": {
        "@rank": "33600", 
        "acronym": "PAM-ICD", 
        "arm_group": [
            {
                "arm_group_label": "Quality of Life Therapy (QOLT)", 
                "arm_group_type": "Experimental", 
                "description": "Positive emotion-focused cognitive behavioral psychotherapy"
            }, 
            {
                "arm_group_label": "Heart Healthy Education (HHE)", 
                "arm_group_type": "Active Comparator", 
                "description": "Heart healthy education program"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this 2-group randomized clinical trial is to: 1) examine the feasibility and\n      acceptability of a 3-month positive-emotion focused therapy (Quality of Life Therapy)\n      modified specifically for patients with implantable cardioverter defibrillator (ICD); and 2)\n      obtain estimates of effect size for QOLT compared to Heart Healthy Education on the changes\n      in arrhythmia frequency and biomarkers of autonomic function, as well as changes in emotion,\n      mood, and well-being across time (baseline, 3 & 9-months). It is hypothesized that the QOLT\n      will promote improvements in autonomic function, reduced arrhythmia frequency, and improved\n      psychological well-being."
        }, 
        "brief_title": "Positive Therapy for Autonomic Function & Mood in ICD Patients", 
        "condition": [
            "Ventricular Arrhythmia", 
            "Implantable Cardioverter Defibrillator"
        ], 
        "condition_browse": {
            "mesh_term": "Arrhythmias, Cardiac"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Adult men and women (\u226518 years of age) who have received an ICD for primary or\n             secondary prevention of sudden cardiac death. All patients will have systolic left\n             ventricular dysfunction due to coronary disease or nonischemic cardiomyopathy. There\n             is no requirement for time since implant;\n\n          2. Score \u22655 on the Hospital Anxiety and Depression Scale (HADS) anxiety or depression\n             scales;\n\n          3. Able to read and write English\n\n          4. Able to commit to the 3-month QOLT/HHE program and 3 assessments over a 9-month\n             duration.\n\n        Exclusion Criteria:\n\n          1. >5% atrial or ventricular pacing;\n\n          2. Sinus node dysfunction;\n\n          3. Persistent and permanent atrial fibrillation (AF) (h/o of paroxysmal AF will be\n             allowed).\n\n          4. Long QT syndrome; and other channelopathies such as Brugada syndrome;\n\n          5. Hypertrophic cardiomyopathy;\n\n          6. Neurocognitive or cognitive impairments;\n\n          7. Severe psychopathology that warrants intensive treatment;\n\n          8. Participation in another research trial; and\n\n          9. Currently in psychological or psychiatric treatment.\n\n         10. Current psychotropic and cardiac medication prescriptions and usage need to be stable\n             (i.e., no change in type or dosage) for 3-months prior to study enrollment."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 18, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02088619", 
            "org_study_id": "Pro00028869", 
            "secondary_id": "1R34HL107733-01A1"
        }, 
        "intervention": [
            {
                "arm_group_label": "Quality of Life Therapy (QOLT)", 
                "intervention_name": "Quality of Life Therapy (QOLT)", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": "Heart Healthy Education (HHE)", 
                "intervention_name": "Heart Healthy Education (HHE)", 
                "intervention_type": "Behavioral"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "psychological wellbeing", 
            "anxiety", 
            "depression", 
            "autonomic functioning"
        ], 
        "lastchanged_date": "March 13, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Charleston", 
                    "country": "United States", 
                    "state": "South Carolina", 
                    "zip": "29425"
                }, 
                "name": "Medical University of South Carolina, Dept of Psychiatry, Division of Bio-Behavioral Medicine"
            }, 
            "investigator": [
                {
                    "last_name": "Eva R Serber, PhD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Michael R Gold, MD, PhD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Positive Psychotherapy to Improve Autonomic Function and Mood in ICD Patients", 
        "other_outcome": [
            {
                "measure": "Florida Shock Anxiety Scale", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "measure": "Florida Patient Acceptance Scale", 
                "safety_issue": "No", 
                "time_frame": "3-months"
            }, 
            {
                "measure": "Emotions Questionnaire", 
                "safety_issue": "No", 
                "time_frame": "3-months"
            }, 
            {
                "measure": "Center for Epidemiologic Studies - Depression Scale (CES-D)", 
                "safety_issue": "No", 
                "time_frame": "3-months"
            }, 
            {
                "measure": "State Trait Anxiety Inventory (STAI)", 
                "safety_issue": "No", 
                "time_frame": "3-months"
            }, 
            {
                "measure": "Life Orientation Test - Revised (LOT-R)", 
                "safety_issue": "No", 
                "time_frame": "3-months"
            }, 
            {
                "measure": "Positive and Negative Affect Schedule (PANAS)", 
                "safety_issue": "No", 
                "time_frame": "3-months"
            }, 
            {
                "measure": "Satisfaction with Life Scale (SWLS)", 
                "safety_issue": "No", 
                "time_frame": "3-months"
            }, 
            {
                "measure": "Quality of Life Inventory (QOLI)", 
                "safety_issue": "No", 
                "time_frame": "3-months"
            }, 
            {
                "measure": "Short-Form Health Survey-36 (SF-36)", 
                "safety_issue": "No", 
                "time_frame": "3-months"
            }, 
            {
                "measure": "Minnesota Living with Heart Failure Questionnaire (MLHFQ)", 
                "safety_issue": "No", 
                "time_frame": "3-months"
            }
        ], 
        "overall_contact": {
            "email": "serbere@musc.edu", 
            "last_name": "Eva R Serber, PhD", 
            "phone": "843-792-0686"
        }, 
        "overall_official": {
            "affiliation": "Medical University of South Carolina", 
            "last_name": "Eva R Serber, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Total arrhythmia frequencies between baseline and 3-months will be the sum of non-sustained ventricular tachycardia (NSVT) detected on the Holter ( \u22656 beats, at >120 beats per minute [BPM] ) plus arrhythmias detected by the ICD", 
                "measure": "Frequency of arrhythmias between baseline and 3-months", 
                "safety_issue": "No", 
                "time_frame": "3-months"
            }, 
            {
                "description": "Total arrhythmia frequencies between 3-months and 9-months will be the sum of non-sustained ventricular tachycardia (NSVT) detected on the Holter ( \u22656 beats, at >120 BPM ) plus arrhythmias detected by the ICD", 
                "measure": "Frequency of arrhythmias between 3-months and 9-months", 
                "safety_issue": "No", 
                "time_frame": "9-months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02088619"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Obtained from ICD interrogation reports from recording between baseline and 3-months", 
                "measure": "Frequency of ICD therapies between baseline and 3-months", 
                "safety_issue": "No", 
                "time_frame": "3-months"
            }, 
            {
                "description": "Index of parasympathetic activity; obtained from 24-hour Holter recording", 
                "measure": "Change in High Frequency heart rate variability (HF-HRV) between baseline and 3-months", 
                "safety_issue": "No", 
                "time_frame": "3-months"
            }, 
            {
                "description": "Obtained from ICD interrogation reports between 3- and 9-months", 
                "measure": "Frequency of ICD therapies between 3-months and 9-months", 
                "safety_issue": "No", 
                "time_frame": "9-months"
            }, 
            {
                "description": "Index of parasympathetic activity; obtained from 24-hour Holter recording", 
                "measure": "Change in High Frequency heart rate variability (HF-HRV) between 3- and 9-months", 
                "safety_issue": "No", 
                "time_frame": "9-months"
            }
        ], 
        "source": "Medical University of South Carolina", 
        "sponsors": {
            "collaborator": {
                "agency": "National Heart, Lung, and Blood Institute (NHLBI)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "Medical University of South Carolina", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}